Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2789474rdf:typepubmed:Citationlld:pubmed
pubmed-article:2789474lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:2789474lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:2789474lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:2789474lifeskim:mentionsumls-concept:C1335671lld:lifeskim
pubmed-article:2789474lifeskim:mentionsumls-concept:C0018284lld:lifeskim
pubmed-article:2789474lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:2789474lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:2789474pubmed:issue3lld:pubmed
pubmed-article:2789474pubmed:dateCreated1989-10-26lld:pubmed
pubmed-article:2789474pubmed:abstractTextThis study was undertaken to explain the molecular basis for the diverse pathology and clinical behavior of postthymic T cell malignancies. Total cellular RNAs were extracted from four HTLV-1 positive and ten HTLV-1-negative T cell lymphomas and cell lines, and investigated for homology with cloned DNA probes specific for interleukin-2 (IL-2), IL-2 receptor (IL-2R), transforming growth factor beta (TGF-beta), platelet-derived growth factor (PDGF), and epidermal growth factor receptor (EGF-R). Tumor cells associated with clinically high grade HTLV-1-positive adult T cell leukemia (ATL) and large cell morphology (T immunoblastic lymphomas) were found to have higher levels of expression of IL-2 and TGF-beta genes than low grade T cell neoplasms (mycosis fungoides and Sezary's syndrome). High expression of IL-2R gene was restricted to Ki-1-positive lymphomas and to one ATL. Cell lines corresponding to the advanced stage of a cutaneous T cell lymphoma (CTCL) showed enhanced expression of PDGF. Therefore, high grade T cell malignancies had consistently elevated expression of growth factor/receptor (GF/R) genes. Expression of EGF-R was negligible in all T cell malignancies. An inverse relationship was found between the expression of T cell antigen receptor (differentiation antigen) and GF/R (activation antigen) genes, accounting for the frequent aberrant expression of T cell antigens in high grade T cell lymphomas. The results suggest that post-thymic T cell malignancies derived from activated T cells produce and secrete GF, conferring a growth advantage on neoplastic T cells, and correlating well with their histologic subtype and clinical behavior.lld:pubmed
pubmed-article:2789474pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:languageenglld:pubmed
pubmed-article:2789474pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2789474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2789474pubmed:statusMEDLINElld:pubmed
pubmed-article:2789474pubmed:monthSeplld:pubmed
pubmed-article:2789474pubmed:issn0002-9440lld:pubmed
pubmed-article:2789474pubmed:authorpubmed-author:KadinM EMElld:pubmed
pubmed-article:2789474pubmed:authorpubmed-author:SuI JIJlld:pubmed
pubmed-article:2789474pubmed:issnTypePrintlld:pubmed
pubmed-article:2789474pubmed:volume135lld:pubmed
pubmed-article:2789474pubmed:ownerNLMlld:pubmed
pubmed-article:2789474pubmed:authorsCompleteYlld:pubmed
pubmed-article:2789474pubmed:pagination439-45lld:pubmed
pubmed-article:2789474pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2789474pubmed:meshHeadingpubmed-meshheading:2789474-...lld:pubmed
pubmed-article:2789474pubmed:meshHeadingpubmed-meshheading:2789474-...lld:pubmed
pubmed-article:2789474pubmed:meshHeadingpubmed-meshheading:2789474-...lld:pubmed
pubmed-article:2789474pubmed:meshHeadingpubmed-meshheading:2789474-...lld:pubmed
pubmed-article:2789474pubmed:meshHeadingpubmed-meshheading:2789474-...lld:pubmed
pubmed-article:2789474pubmed:meshHeadingpubmed-meshheading:2789474-...lld:pubmed
pubmed-article:2789474pubmed:meshHeadingpubmed-meshheading:2789474-...lld:pubmed
pubmed-article:2789474pubmed:meshHeadingpubmed-meshheading:2789474-...lld:pubmed
pubmed-article:2789474pubmed:meshHeadingpubmed-meshheading:2789474-...lld:pubmed
pubmed-article:2789474pubmed:meshHeadingpubmed-meshheading:2789474-...lld:pubmed
pubmed-article:2789474pubmed:meshHeadingpubmed-meshheading:2789474-...lld:pubmed
pubmed-article:2789474pubmed:meshHeadingpubmed-meshheading:2789474-...lld:pubmed
pubmed-article:2789474pubmed:year1989lld:pubmed
pubmed-article:2789474pubmed:articleTitleExpression of growth factor/receptor genes in postthymic T cell malignancies.lld:pubmed
pubmed-article:2789474pubmed:affiliationDepartment of Pathology, National Taiwan University Hospital, Taipei, Republic of China.lld:pubmed
pubmed-article:2789474pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2789474pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2789474pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2789474lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2789474lld:pubmed